Shire plc, the global specialty biopharmaceutical company, announces that it has signed a last minute agreement to acquire Advanced BioHealing, Inc a day before it was said to go public. Shire is paying $750 million cash, which implies slightly more than five times Advnaced BioHealing sales lat year. If you are interested in more details about this transaction, please check out our deal profile below.
– Implied Enterprise Value ($mm) $750
– LTM Sales ($mm) $147 – EV/Sales 5.1x
– LTM EBITDA ($mm) $30 – EV/EBITDA 35.7x